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Introduction
Hemangioma is a congenital benign tumor of vascular 
tissue that arises from rapid endothelial cell proliferation 
followed by gradual involution. It can sometimes be 
missed at birth but then noticed during the first 8 weeks of 
life. There may be a regression period during adulthood. 
The progressive and developmental period occurs as age 
increases.1 These vascular anomalies have stricken up 
to 10% of newborns. The new classification of vascular 
anomalies identifies two main categories; vascular tumors 
and arteriovenous malformations (AVM). Hemangioma 
is a tumor of rapidly growing endothelial cells in which 
blood architectures have incomplete and hyperplasic cells, 
but vascular malformations do not contain hyperplasic 
cells and are formed by progressively enlarging aberrant 
and ectatic vessels composed of the type of vessel involved 
i.e. capillary, veins, arteriovenous.
Thus, these lesions are considered as their predominant 
vessel type i.e. venous malformations, AVMs or classified 
according to the hemodynamic features (low flow or high 
flow).2-4 Hemangioma is predominantly distributed on 
head and neck.5 The classic treatments for these lesions 
are sclerotherapy with injection of sclerosant agents and 
surgery that occasionally results in complications such as: 
significant deformity, prolonged pain, skin necrosis, nerve 
damage, systemic toxicity and hemorrhagic phenomenon. 
Because of these complications, laser therapy has been 
recently introduced as one of the main treatments of 
vascular lesions.6,7
Different kinds of laser systems have been applied for 
clinical use in treatment of hemangioma and vascular 
malformations since 1980s, such as carbon dioxide laser 
(CO2), argon, diode, erbium-doped yttrium aluminum 
garnet (Er:YAG), potassium-titanyl-phosphate (KTP), 
pulsed dye laser (PDL) and neodymium-doped yttrium 
aluminium garnet (ND:YAG) lasers.8
Laser Mechanism of Action
Human maxillofacial tissues consist of different tissues; 
thus the clinician must first choose the appropriate laser 
for each treatment. Different types of lasers are applied in 
regard to specific tissues, e.g. for soft tissue treatments, 
the practitioner can use any available wavelength. All 
laser photons are absorbed by one or more of the soft 
tissue components. Lasers with short wavelengths (diode, 
Nd:YAG) are nonreactive with healthy tooth enamel; 
however, Er:YAG can remove hard and soft tissues near 
the operation site. Each laser’s effect on tissue can be 
different, for example erbium and Co₂ lasers are absorbed 
in high water contained tissues and because of their 
wavelengths, these lasers can penetrate only a few micron 
deep into the target tissue. Whereas the Nd:YAG laser 
can reach a few millimeters deep in the tissue. It should 
be considered that the relative penetration of different 
wavelengths varies. Also the penetration of laser photons 
into mucosa and tissue may occur beyond the surgical 
field.9
The final aim of laser therapy for hemangioma and 
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other similar lesions is the selective destruction of 
tumoral vessels through the absorption of laser photons 
by hemoglobin molecules in red blood cells. Thermal 
energy of laser photons scatters radially within the blood 
vessel inducing selective microvascular hazardous effects, 
through photocoagulation and mechanical injury. The 
chosen wavelength should be absorbed selectively by 
hemoglobin molecules. Several factors such as the size 
of vessels, depth of the lesion, area of body treated, laser 
spot size, skin type and fluence can affect the absorption 
of laser. There are several types of lasers used in laser 
surgery. There are 3 types of mode of operation including 
continuous wave lasers (CWLs) such as CO2, argon 
and diode laser, pulsed laser systems such as Nd:YAG 
and Er:YAG lasers, chopped mode which is a variety of 
continuous mode that have equal power photons, but have 
many equal distance interruptions in milliseconds.10-12 
Argon Laser
This type of laser has a wavelength of 514 nm and is 
observed as green light. This laser is able to penetrate 
into the skin and mucosa to a depth of 0.5 mm and 
photocoagulate the hemoglobin molecules in the vessels. 
Thus, this laser can microscopically remove superficial 
hemangioma. The laser photons are absorbed by 
hemoglobin and cause coagulation necrosis of dermis, 
and vascular embolization of the papillary layer without 
harm to cutaneous appendages. This type of laser has 
a precise effect for removing superficial telangiectasia 
and small, flat hemangioma, but in deeper and larger 
hemangioma it has a variable response, for which it has 
recently been replaced with pulsed lasers.5,10 
Flashlamp-Pumped Pulse Dye Laser 
This laser was designed for cutaneous vascular lesions 
treatment without scar formation. This type of laser has 
2 wavelengths of 585 and 595 nm. The laser photons 
destruct blood vessels by using an exposure time less than 
the calculated thermal relaxation time (1–10 ms) for the 
blood vessels. It was advocated that an exposure time of 
a millisecond or less is required to confine the heat to the 
vessel in order to decrease the risk of heat diffusion, and 
skin scarring. This laser can induce thrombosis within the 
vessels without damage to the dermis. With use of 585 nm, 
the penetration depth for 50% of the energy is calculated 
to be 0.8 mm.
 
On the other hand, the dermis of facial skin 
is approximately 0.6 mm deep in children and 0.9 mm 
in adults. Therefore, FPDL has proved to be a safe and 
effective treatment modality for superficial hemangioma 
in the face. Immediately after laser radiation, the color 
of the treated area turns to blue-lilac (purpuric) color, 
with surrounding erythematous flare which resolves in 7 
to 14 days after laser therapy. The side effects comprise 
edema, especially in the periorbital area. If the epidermis 
becomes blanching or graying during application, the 
energy fluences should be reduced to avoid blisters. After 
treatment, the treated areas are covered with panthenol 
ointment in order to improve hydration, reduce itching 
and inflammation of the skin, and accelerate epidermal 
wound healing. In a condition were blistering or crusting 
occurs, povidone-iodine solution is recommended. The 
application of this type of laser has no benefit in deeper 
procedures. The superficial compartment resolve but 
the deeper compartment continues to proliferate or not 
be affected during laser therapy. Therefore, it has been 
suggested to use corticosteroids and Nd:YAG laser for 
treatment of these types or sequential use of PDL with 
wavelength of 595 nm and Nd:YAG laser in treatment of 
lesions resistant to conventional treatment of PDL.13-15 
Nd:YAG Laser
Nd:YAG laser is a kind of solid state laser that has a 
wavelength of 1064 nm which emits an infrared invisible 
light in continuous wave with a penetration depth of 
1.0 mm. The laser energy can be absorbed mostly by 
blood vessels, the laser photons are also absorbed in 
surrounding tissues. This type of laser can penetrate 
in deeper lesions and create photocoagulation and 
hemostasis with little edema and bleeding because of its 
wavelength. Ice cubes can be used to cool the area during 
irradiation for prevention of damage to surrounding 
tissues. The percutaneous or intralesional application 
technique is a valuable tool for subcutaneous or mixed 
hemangioma cases with larger or deeper compartments 
(2 cm in depth). The laser beam has a spot diameter with 
a size of 2 mm on the surface of the lesion. The output 
power of the laser is variable between 20 to 50 W. For the 
treatment of cases with smaller deep red hemangiomas, 
the lower range of output power i.e. 20 to 34 W is chosen 
with continuous cooling using ice cubes. However, in 
thicker subcutaneous hemangiomas, a higher output 
power about 50 W is applied with continuous ice cooling. 
Subcutaneous hemangiomas should be treated in 
repeated sessions with interval treatment course of 4 
to 6 weeks. Intraoral hemangioma has been treated 
with output power of 4 to 8 W in many sessions and 
short times without cooling. Unfortunately, some of 
these lesions almost develop rapidly, and repeated laser 
treatment is helpful to slow progress of this process and 
to accelerate resolution.16 Treatment of intraoral lesions 
occurs through vaporization or excision depending on 
the size and proximity of the lesions to vital compartment 
e.g. neural, vascular, and salivary.17 The treatment is done 
in phases every three months to control and examine the 
reduction of growth and size of the lesion in the buccal, 
lingual, gingival, and palatal areas.
The settings with optimum results are an output power 
of 400–600 J/cm2 with pulse duration of 0.5 seconds in 
surface noncontact application mode.2,18 This treatment 
is very painful and should be performed under general 
anesthesia. After treatment, the lesion area becomes 
swollen and will acquire a rigid consistency immediately. 
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The blistering or a scab on the surface of affected area 
may appear. The swelling often resolves within 1 week 
after treatment, and the lesion becomes flat and blanched 
during 2 to 4 weeks post-treatment. The response rate of 
laser therapy for hemangioma is variable between 77% 
and 100%. The size of hemangioma at initial treatment 
is an important issue, the smaller size lesions have better 
therapeutic results.19 There are some complications that 
have been reported such as; hyper-pigmentation, scarring, 
atrophy of operating tissue, and dyspigmentation which is 
due to spontaneous remission of large hemangioma.5,18
CO₂ Laser
This laser has a wavelength of 10600 nm and the best 
absorption in high water composed tissues and is 
considered as an ideal laser in soft tissue surgery. This 
type of laser has two modes; continuous wave and 
ultra-pulsed system. In continuous mode, production 
of equal beams of light causes rapid tissue vaporization 
and cellular destruction occurs through photothermal 
effect. The cells absorb photons’ energy, which leads to 
vaporization of cellular water and cellular interruption 
before conduction of heat in surrounding tissue, creating 
a zone of necrosis about 500 µm or less. The composition 
of pigmentation and vascularization is not important in 
Co₂ laser application. The coagulation of vessels up to 
500 µm diameters and hemostasis reduces postsurgical 
bacteremia better than other surgical methods.
This laser improves the surface texture appearance.10,20 
This type of laser is successfully used for tongue reduction 
in macroglossia, and also in treatment of intraoral 
hemangioma, especially tongue and lips. The excision 
of tumor, hemostasis by coagulation and vaporization, 
in addition to the safety, easily performed operation and 
diminished hospitalization and medical expenses for the 
patient makes this type of laser one of the best methods 
for treatment of hemangioma. While Co₂ laser is more 
used in treatment of superficial hemangioma, the healing 
period is longer than in other methods.21,22
KTP Laser
This laser has double the frequency of Nd:YAG laser and is 
one of the solid state lasers. It has a wavelength of 532 nm 
and emits short pulses and high peak power photons that 
differ from argon laser and is observed as green light. The 
clinical effect has been noted to be between argon laser 
and flashed-pumped PDL.23 This wavelength is in about 
the hemoglobin absorption peak and high absorption of 
photons by hemoglobin occurs. This laser is a suitable 
vehicle for treatment of superficial hemangioma. It has 
a wide range of pulse duration from 1 to 100 ms which 
leads to longer pulse duration and slow heat conduction 
to blood vessel without rupture of blood vessel walls. 
Because of deeper penetration and coagulation, it is 
better than Co₂ laser application, especially in subglottic 
area. However this laser has many complications such as 
edema, purpura and crusting.16,24
Er:YAG Laser 
This laser type belongs to solid state lasers and the erbium 
family laser which has two wavelengths, the Er:YAG with 
2940 nm wavelength, and the Er-Cr:YAG with 2780 nm 
wavelength. Both of them have pulsed mode of operation 
and delivery systems as mirrored hand-pieces with 
articulated arm or fibers conduction systems. These lasers 
have highest absorption in water and hydroxyapatite 
ions. They have been applied for removing hard and soft 
tissues of oral cavity such as dental caries, osteoplasty, 
exophytic tissue and frenectomy. Vaporization of water 
molecules within hard tissues creates micro-explosions 
in the hydroxy-apatite molecules (ablation phenomenon) 
leading to a break down of hard tissue without charring 
and carbonization, while causing minimal heat generation. 
The erbium lasers ablate soft tissue and are most effective 
in lightly vascularized tissue where bleeding will not be an 
issue and has been least effective in achieving hemostasis, 
but Er-Cr: YSGG is more efficient than Er:YAG and is used 
in gingivectomy, frenectomy and crown lengthening. The 
delivery systems comprise a water spray to prevent heat 
damage to tissues, rehydrating target tissues in order for 
photon’s energy to be better absorbed by the target organ. 
Interstitial photocoagulation is produced in treatment of 
hemangioma like with other lasers such as; ND:YAG laser 
which led to regression of lesion and no reperfusion, also 
no scar formation has been reported.10,15
Intense Pulsed Light
This laser has high-intensity light sources that can emit 
polychromatic light. Unlike other laser systems, these flash 
lamps exit non-coherent light in wavelength spectrum 
from 500 nm to over 1100 nm and working energies up to 
80 J/cm2. There are many filters that minimize the emitted 
light in range of 515 and 590 nm. The emitted light may 
be single, double, or triple pulses in the millisecond range.
These pulse durations protect the outer epidermis. These 
adjustable wavelengths and pulse durations provide good 
diversity in the treatment of a variety of lesions such as 
vascular and pigmented lesions for different skin types. 
This system has a cooling device, but generally the 
temporary erythema is the only acute side effect. On 
the basis of properties of this laser, treatment of benign 
cavernous hemangioma, benign venous malformations, 
essential facial telangiectasia and port wine stains are 
possible.26
Laser Treatment of Port-Wine Stains
Port-wine stain (PWS) is defined as birthmarks or vascular 
malformations consisting of ectatic blood vessels in the 
papillary and upper reticular dermis. Many types of lasers 
were applied for treatment of this disorder such as CO2, 
Nd:YAG and cooper vapor laser, but the PDL therapy is 
the standard approach for treating these birthmarks. The 
success rate of total treatment with the PWS is about 
10%. The result of treatment is different in individuals 
and sites from person to person. The presumed aim of 
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laser treatment is acute photocoagulation of the PWS 
microvasculature. Clinically a common sign used to 
assess photocoagulation is purpura (bluish-gray skin 
discoloration from blood extravasation) formation, 
although the purpura formation may occur without 
photocoagulation.25 The incidence of removing lesion 
by this technique is as yet un-documented. On the other 
hand, red lesions are more resistant to treatment than the 
light pink lesions. Recently, it has been recognized that the 
degree of response correlates to the anatomical location 
of the PWS. Also some researches revealed that patients 
under 4 years of age need less treatment to reach the same 
degree of response. The mid-face location of port wine 
stain has slower response to pulse dye laser treatment 
compared to other locations.4,27
During laser treatment, the cooling chamber leads to 
significant reduction of pain sensation. The infants 
over 7 years can often be treated without anesthesia, 
although this is related to the size and anatomic site of the 
lesion. While in child cases with extensive lesions or in 
central facial PWSs, general anesthesia especially for eye 
protection is beneficial. The treatment of port wine stain 
should take place as early as possible, since in addition 
to the abnormality of face, the port wine stain has a 
considerable degree of psychological morbidity.27
Comparisons of Lasers
Hemangioma treatment with laser systems has different 
outcomes with one laser system having better therapeutic 
effect in the treatment course. PDL laser system has the 
best documented safety record in laser systems. Another 
advantage of this laser is its application for different age 
groups. Laser therapeutic effects are almost limited to the 
superficial portions of hemangioma. Laser treatments 
with PDL system do not diminish the development of 
deeper content of hemangioma. It is difficult to deal 
with deeper components in hemangioma, so the deeper 
component of the lesion may still grow after treatment, 
in spite of the superficial component having been 
successfully treated. The effectiveness of PDL on deeper 
component of hemangioma is not well established, 
lesions thicker than 3 mm may not respond well to PDL. 
Superficial ectatic blood vessels of incompletely regressed 
hemangioma can be treated with PDL. In the laser 
treatment of childhood hemangioma, it was seen that the 
application of long pulsed PDL is safer and more effective 
than PDL. For deep components of hemangioma, the 
longer-wavelength, deeper-penetrating lasers, such as 
the Nd:YAG laser, have been tried with variable results. 
Ulcerated hemangiomas are painful and require local 
anesthesia (1% lignocaine). Lesions involving larger areas 
need topical, local or general anesthesia
It has been proven that Nd:YAG laser therapy can 
be effective in the treatment of superficial venous 
malformations, but in deeper lesions because of photon 
energy absorption in skin and mucosa, low level laser 
therapy in many sessions may be beneficial in the 
shrinkage of hemangioma.19 In a research conducted 
by Raulin and Greve28 the comparison of the efficacy 
of PDL with long-pulsed frequency-doubled Nd:YAG 
were evaluated, the result of this research showed the 
regression rate of hemangioma was somewhat higher 
with PDL laser usage. In Poetke and Berlien study,39 the 
excellent response in treatment of hemangioma was 53%. 
In another studides the application of PDL was quick, 
effective, and almost devoided of side effects and specially 
showed improved effects in treatment of ulcerated 
hemangioma.30-33 Nd:YAG has many side effects such as 
swelling, blistering, crust formation, which was more than 
PDL laser, on the other hand purpura formation, hypo 
and hyperpigmentation creation were more than Nd:YAG 
laser. These side effects in Nd:YAG laser applications are 
due to deep thermal hazards from intensely penetrating 
infrared light wavelength of this laser type. Nd:YAG laser 
has a narrow band of safety and efficacy. Researchers 
insist on the KTP laser as an efficient treatment of deep 
hemangiomas, because this laser system can be used with 
the low output power 2 to 5 W) and the ulceration rate is 
decreased from 20% to 2%. 
The smaller output power leads to selective absorption 
rather than thermal effect and low ulceration rate, as 
well as, both the superficial and deep components of the 
hemangioma can be treated together simultaneously.30
Contraindication of laser therapy in hemangioma 
treatment
There are some contraindications that are both absolute 
and relative, the absolute contraindications are: Active 
local infection or photo-aggravated skin diseases and 
medical conditions. The relative contraindications are: 
unstable vitiligo, psoriasis, keloid and keloidal tendencies, 
patient on isotretinoin or patient who is not cooperative 
or has unrealistic expectations.31
 
Conclusion
There are many laser systems used in the treatment of 
hemangioma and vascular tumors. These laser systems 
have different wavelengths and penetration depths, 
however, they have similar mechanisms and in some cases 
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